The latest quarterly R&D expense is $34.06 Million with a QoQ Growth of +12.26%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $34.06M.
$34.06M
$34.06 Million
Q2 FY2026 · 2026-06-30
+12.26%
vs. $30.34M prior quarter
13
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $34.06M | +12.26% | -87.84% |
| Q1 FY2026Period end 2026-03-31 | $30.34M | -7.38% | +29.10% |
| Q4 FY2025Period end 2025-12-31 | $32.76M | +2.61% | +46.42% |
| Q3 FY2025Period end 2025-09-30 | $31.92M | -88.60% | +34.21% |
| Q2 FY2025Period end 2025-06-30 | $279.96M | +1091.33% | +1023.44% |
| Q1 FY2025Period end 2025-03-31 | $23.50M | +5.05% | -23.61% |
| Q4 FY2024Period end 2024-12-31 | $22.37M | -5.94% | -21.72% |
| Q3 FY2024Period end 2024-09-30 | $23.79M | -4.55% | -16.42% |
| Q2 FY2024Period end 2024-06-30 | $24.92M | -18.99% | -10.36% |
| Q1 FY2024Period end 2024-03-31 | $30.76M | +7.65% | N/A |
| Q4 FY2023Period end 2023-12-31 | $28.58M | +0.43% | N/A |
| Q3 FY2023Period end 2023-09-30 | $28.46M | +2.36% | N/A |
| Q2 FY2023Period end 2023-06-30 | $27.80M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.